Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin ...
FDA Drug Recall #D-0667-2025 — Class II — September 12, 2025
Recall Summary
| Recall Number | D-0667-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 12, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Private Label Skin Care Inc. |
| Location | Canoga Park, CA |
| Product Type | Drugs |
| Quantity | N/A |
Product Description
Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin Institute, 650 University Ave, Ste 200, Sacramento, CA 95825.
Reason for Recall
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Distribution Pattern
CA, GA only
Lot / Code Information
Lot # 58170A and 58172A, Exp Date: 09/2025
Other Recalls from Private Label Skin Care Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0668-2025 | Class II | edunn clarity, BP Treatment Cleanser 10% (Benzo... | Sep 12, 2025 |
| D-0663-2025 | Class II | ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (... | Sep 12, 2025 |
| D-0666-2025 | Class II | mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne... | Sep 12, 2025 |
| D-0664-2025 | Class II | Skin MD by Dr Monika Kiripolsky, Body Acne Clea... | Sep 12, 2025 |
| D-0665-2025 | Class II | Torrey Pines Dermatology & Laser Center Benzade... | Sep 12, 2025 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.